Abstract
Introduction: Granulomatous mycosis fungoides (GMF) is a rare variant of MF/cutaneous T-cell lymphoma (CTCL) characterized by epidermotropism and granulomatous infiltrates. Although an enhanced immune response associated with granulomatous formation may indicate a good prognosis in MF patients, cases with aggressive course have also been reported. Given the variable skin manifestations of GMF and the lack of typical patch/plaque lesions in some cases, we aimed to perform a clinical analysis of GMF patients focusing attention on clinical features and impact on prognosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
